Clinic
Dothouse Health INC.
Dothouse Health INC. was paid $39.00M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoDOTHOUSE HEALTH INC.
DORCHESTER, MA 02122
DORCHESTER, MA 02122
33aNPI1578514733assigned 05/13/2006
33bProvider typeClinic/Center
28Total paid$39.00M
24GClaims937,250
24DCodes billed228
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Massachusetts
Rank by total paid#5 of 53
Median peer was paid$154K
This provider vs. median253×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 151,519 | $6.29M | |
| 2019 | 142,645 | $5.89M | |
| 2020 | 115,593 | $5.76M | |
| 2021 | 145,690 | $6.65M | |
| 2022 | 125,693 | $6.68M | |
| 2023 | 126,947 | $4.19M | |
| 2024incomplete | 129,163 | $3.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 170,236 | 151,261 | $12.48M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 82,688 | 77,736 | $6.33M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.7% | 28,419 | 27,772 | $2.23M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.8% | 24,480 | 21,851 | $1.88M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.3% | 18,443 | 12,925 | $1.29M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.5% | 10,071 | 9,392 | $966K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.1% | 9,695 | 9,684 | $835K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.9% | 8,748 | 8,737 | $742K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 8,587 | 8,579 | $740K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.7% | 7,241 | 7,031 | $655K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1.4% | 19,717 | 16,469 | $559K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.4% | 6,541 | 6,432 | $550K |
216 more codes
| D9450 | 1.4% | 49,062 | $547K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.3% | 6,283 | $499K |
| D1110 | Prophylaxis - adult | <1% | 13,597 | $376K |
| 90651 | <1% | 4,238 | $331K | |
| 90686 | <1% | 19,705 | $318K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,571 | $317K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 8,278 | $298K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 7,053 | $298K |
| D1120 | Dental cleaning, child | <1% | 5,105 | $255K |
| D0120 | Dental checkup, returning patient | <1% | 14,942 | $237K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,566 | $233K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 20,065 | $205K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 10,174 | $204K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 4,182 | $189K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 5,873 | $177K |
| 92015 | Determination of refractive state | <1% | 14,188 | $173K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,626 | $166K |
| D1206 | Topical application of fluoride varnish | <1% | 6,299 | $162K |
| 99050 | <1% | 9,800 | $159K | |
| 97802 | <1% | 2,561 | $139K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 3,771 | $133K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,139 | $127K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 19,979 | $125K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 5,391 | $125K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,447 | $122K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 21,163 | $118K |
| 90715 | <1% | 5,790 | $115K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 4,597 | $114K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,532 | $113K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17,281 | $106K |
| D0274 | Bitewings - four radiographic images | <1% | 4,762 | $104K |
| 0001A | <1% | 2,874 | $103K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,344 | $99K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,349 | $99K |
| 0002A | <1% | 2,688 | $99K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,910 | $90K |
| 99381 | <1% | 765 | $89K | |
| V2020 | Frames, purchases | <1% | 950 | $76K |
| 86703 | <1% | 8,650 | $76K | |
| 90670 | <1% | 3,605 | $72K | |
| 80061 | Lipid panel | <1% | 18,378 | $72K |
| 90480 | <1% | 1,883 | $69K | |
| 92341 | <1% | 2,056 | $68K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,587 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,182 | $63K |
| 86780 | <1% | 5,845 | $62K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 655 | $57K |
| 99173 | <1% | 2,756 | $57K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 5,096 | $56K |
| D1351 | Sealant - per tooth | <1% | 1,458 | $56K |
| 86803 | <1% | 6,169 | $55K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 320 | $54K |
| 82274 | <1% | 4,788 | $53K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 462 | $52K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 839 | $50K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 375 | $50K |
| 97803 | <1% | 1,023 | $49K | |
| 90734 | <1% | 1,969 | $46K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 611 | $43K |
| 90677 | <1% | 1,252 | $41K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,169 | $41K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 382 | $41K |
| 80053 | Comprehensive metabolic panel | <1% | 8,255 | $40K |
| 90716 | <1% | 1,704 | $38K | |
| 99051 | <1% | 6,071 | $37K | |
| 0012A | <1% | 991 | $36K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 342 | $35K |
| 0004A | <1% | 781 | $35K | |
| 90633 | <1% | 3,569 | $31K | |
| 85027 | <1% | 5,869 | $31K | |
| 86706 | <1% | 4,546 | $30K | |
| 0011A | <1% | 900 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,327 | $27K |
| D2331 | <1% | 646 | $26K | |
| D0272 | Bitewings - two radiographic images | <1% | 879 | $25K |
| D2740 | Crown - porcelain/ceramic | <1% | 80 | $24K |
| 90691 | <1% | 1,076 | $23K | |
| 84703 | <1% | 4,415 | $23K | |
| 0134A | <1% | 689 | $23K | |
| D0330 | Panoramic radiographic image | <1% | 396 | $22K |
| 99385 | <1% | 345 | $21K | |
| D0180 | <1% | 1,299 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,998 | $19K |
| 0064A | <1% | 551 | $18K | |
| 90739 | <1% | 867 | $18K | |
| 99188 | <1% | 655 | $18K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,606 | $17K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,754 | $17K |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 251 | $17K |
| 0054A | <1% | 411 | $17K | |
| 90707 | <1% | 1,740 | $16K | |
| 90656 | <1% | 901 | $15K | |
| 0071A | <1% | 318 | $14K | |
| D2330 | <1% | 421 | $14K | |
| 0031A | <1% | 473 | $14K | |
| 90680 | <1% | 995 | $13K | |
| 92133 | <1% | 737 | $13K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 119 | $12K |
| 81025 | <1% | 2,371 | $12K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 183 | $12K |
| 99442 | <1% | 630 | $12K | |
| 82043 | <1% | 2,790 | $12K | |
| 87210 | <1% | 2,961 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 423 | $11K |
| 90887 | <1% | 359 | $11K | |
| 87430 | <1% | 1,080 | $11K | |
| 0072A | <1% | 245 | $11K | |
| 0124A | <1% | 467 | $11K | |
| D4341 | <1% | 351 | $11K | |
| 99441 | <1% | 483 | $11K | |
| 82570 | <1% | 2,734 | $10K | |
| 81003 | <1% | 5,493 | $9K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 120 | $9K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 84 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 729 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 280 | $7K |
| 99443 | <1% | 662 | $7K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 233 | $7K |
| 87340 | <1% | 728 | $6K | |
| 80076 | <1% | 940 | $6K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,005 | $6K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,781 | $6K |
| ATP14 | <1% | 531 | $5K | |
| 97810 | <1% | 377 | $5K | |
| 90696 | <1% | 826 | $5K | |
| 86580 | <1% | 584 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,272 | $4K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 147 | $4K |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 148 | $4K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 52 | $4K |
| 99386 | <1% | 93 | $4K | |
| 90733 | <1% | 684 | $4K | |
| 99383 | <1% | 39 | $3K | |
| 90648 | <1% | 1,556 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 52 | $3K |
| 0013A | <1% | 73 | $3K | |
| 90710 | <1% | 985 | $3K | |
| 85018 | <1% | 1,323 | $3K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 29 | $3K |
| 80050 | General health panel | <1% | 154 | $3K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 3,158 | $2K |
| 90732 | <1% | 117 | $2K | |
| 11721 | <1% | 153 | $2K | |
| 0052A | <1% | 50 | $2K | |
| H0046 | Mental health services, not otherwise specified | <1% | 92 | $2K |
| 83014 | <1% | 329 | $2K | |
| 90713 | <1% | 311 | $2K | |
| 69210 | <1% | 12 | $2K | |
| ATP08 | <1% | 209 | $2K | |
| 81001 | <1% | 658 | $2K | |
| D2950 | <1% | 30 | $2K | |
| 92083 | <1% | 70 | $2K | |
| 0051A | <1% | 32 | $1K | |
| 90714 | <1% | 43 | $1K | |
| 90678 | <1% | 13 | $1K | |
| 83721 | <1% | 228 | $1K | |
| 0111A | <1% | 40 | $1K | |
| 0144A | <1% | 29 | $1K | |
| 90632 | <1% | 37 | $1K | |
| 99397 | <1% | 92 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 32 | $945.58 |
| 84460 | <1% | 287 | $859.16 | |
| 82947 | <1% | 166 | $819.42 | |
| 0154A | <1% | 17 | $779.79 | |
| 92134 | <1% | 42 | $766.23 | |
| 84702 | <1% | 55 | $735.49 | |
| 0074A | <1% | 33 | $652.98 | |
| 90744 | <1% | 1,454 | $578.69 | |
| ATP17 | <1% | 54 | $576.74 | |
| 90723 | <1% | 462 | $566.64 | |
| 0112A | <1% | 12 | $550.56 | |
| ATP03 | <1% | 107 | $508.00 | |
| 90698 | <1% | 1,451 | $478.06 | |
| 92551 | <1% | 43 | $409.67 | |
| 85610 | <1% | 113 | $405.48 | |
| 91301 | <1% | 1,662 | $361.74 | |
| 90700 | <1% | 933 | $293.91 | |
| 90461 | <1% | 369 | $291.51 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 79 | $279.95 |
| 90661 | <1% | 534 | $169.38 | |
| 93000 | <1% | 12 | $154.13 | |
| 91306 | <1% | 422 | $120.02 | |
| 90473 | <1% | 915 | $119.01 | |
| ATP11 | <1% | 13 | $118.43 | |
| S3005 | Performance measurement, evaluation of patient self assessment, depression | <1% | 12 | $106.30 |
| 84450 | <1% | 38 | $101.86 | |
| 90746 | <1% | 12 | $70.90 | |
| 85014 | <1% | 26 | $63.44 | |
| 90474 | <1% | 76 | $57.12 | |
| 2022F | <1% | 1,440 | $43.02 | |
| 99000 | <1% | 44 | $40.60 | |
| 99406 | <1% | 17 | $10.98 | |
| 81015 | <1% | 29 | $5.38 | |
| D1330 | <1% | 90 | $2.80 | |
| 91322 | <1% | 1,528 | $0.20 | |
| 91305 | <1% | 593 | $0.03 | |
| 90681 | 0% | 382 | $0.00 | |
| 91300 | 0% | 6,269 | $0.00 | |
| 91313 | 0% | 698 | $0.00 | |
| 91312 | 0% | 462 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 29 | $0.00 |
| 91321 | 0% | 312 | $0.00 | |
| 90685 | 0% | 130 | $0.00 | |
| 91311 | 0% | 84 | $0.00 | |
| 91308 | 0% | 12 | $0.00 | |
| 2020F | 0% | 65 | $0.00 | |
| 91303 | 0% | 482 | $0.00 | |
| 90619 | 0% | 44 | $0.00 | |
| 90697 | 0% | 640 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 70 | $0.00 |
| 91307 | 0% | 269 | $0.00 | |
| 91314 | 0% | 31 | $0.00 | |
| 90688 | 0% | 12 | $0.00 | |
| 91315 | 0% | 19 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 27 | $0.00 |
| 36416 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAMPION, SHARON (CREDENTIALING COORDINATOR)
Parent organizationDOTHOUSE HEALTH INC.